Literature DB >> 19413728

The spleen plays a central role in primary humoral alloimmunization to transfused mHEL red blood cells.

Jeanne E Hendrickson1, Natia Saakadze, Chantel M Cadwell, Jason W Upton, Edward S Mocarski, Christopher D Hillyer, James C Zimring.   

Abstract

BACKGROUND: Several differences exist between antigens on transfused red blood cells (RBCs) and other immunogens, including anatomical compartmentalization. Whereas antigens from microbial pathogens and solid organ transplants drain into local lymph nodes, circulating RBCs remain segregated in the peripheral circulation, where they are consumed by antigen-presenting cells (APCs) in the spleen and liver. Accordingly, it was hypothesized that the splenic APCs play a central role in primary alloimmunization to transfused RBCs. STUDY DESIGN AND METHODS: Recipient mice were splenectomized and transfused with transgenic RBCs expressing the membrane-bound hen egg lysozyme (mHEL) model RBC antigen. In some experiments, mHEL-specific CD4+ T cells were adoptively transferred into recipient mice to allow investigation of helper T-cell responses. Unmanipulated or sham-splenectomized mice served as controls. Recombinant murine cytomegalovirus expressing mHEL (mHEL-MCMV) was used as a control non-RBC immunogen. Humoral responses were measured by mHEL-specific enzyme-linked immunosorbent assay and flow cytometric–based RBC cross-match.
RESULTS: Control animals synthesized detectable anti-HEL immunoglobulin (Ig)G after a single mHEL RBC transfusion. mHEL-specific CD4+ T cells underwent robust expansion, and adoptive transfer of CD4+ T cells resulted in a 1000-fold increase in anti-HEL IgG. In contrast, minimal anti-HEL IgG was detectable in splenectomized mice, mHEL-specific CD4+ T cells did not proliferate, and adoptive transfer did not increase anti-HEL IgG. However, anti-HEL IgG response after exposure to mHEL-MCMV was equivalent in control and splenectomized mice. DISCUSSION: Together, these findings illustrate the distinct properties of transfused RBCs as immunologic stimuli, with the spleen playing a critical role in primary RBC alloimmunization at the level of CD4+ T-cell activation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19413728      PMCID: PMC3568957          DOI: 10.1111/j.1537-2995.2009.02200.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  17 in total

1.  The danger model: a renewed sense of self.

Authors:  Polly Matzinger
Journal:  Science       Date:  2002-04-12       Impact factor: 47.728

2.  Alloimmunization in Hong Kong southern Chinese transfusion-dependent thalassemia patients.

Authors:  H K Ho; S Y Ha; C K Lam; G C Chan; T L Lee; A K Chiang; Y L Lau
Journal:  Blood       Date:  2001-06-15       Impact factor: 22.113

3.  Analysis of immune response to red blood cell antigens in multitransfused patients with different diseases.

Authors:  H Seyfried; I Walewska
Journal:  Mater Med Pol       Date:  1990 Jan-Mar

4.  Multiple red cell transfusions and alloimmunization. Experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993.

Authors:  G A Hoeltge; R E Domen; L A Rybicki; P A Schaffer
Journal:  Arch Pathol Lab Med       Date:  1995-01       Impact factor: 5.534

5.  Insertional mutagenesis of the murine cytomegalovirus genome: one prominent alpha gene (ie2) is dispensable for growth.

Authors:  W C Manning; E S Mocarski
Journal:  Virology       Date:  1988-12       Impact factor: 3.616

6.  Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly asian descent.

Authors:  S T Singer; V Wu; R Mignacca; F A Kuypers; P Morel; E P Vichinsky
Journal:  Blood       Date:  2000-11-15       Impact factor: 22.113

7.  A prospective study to determine the frequency and clinical significance of alloimmunization post-transfusion.

Authors:  N M Heddle; R L Soutar; P L O'Hoski; J Singer; J A McBride; M A Ali; J G Kelton
Journal:  Br J Haematol       Date:  1995-12       Impact factor: 6.998

8.  Cytomegalovirus determinant of replication in salivary glands.

Authors:  W C Manning; C A Stoddart; L A Lagenaur; G B Abenes; E S Mocarski
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

9.  B-1a B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen.

Authors:  Hedda Wardemann; Thomas Boehm; Neil Dear; Rita Carsetti
Journal:  J Exp Med       Date:  2002-03-18       Impact factor: 14.307

10.  Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells.

Authors:  W Y Ho; M P Cooke; C C Goodnow; M M Davis
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

View more
  17 in total

Review 1.  Use of mouse models to study the mechanisms and consequences of RBC clearance.

Authors:  E A Hod; S A Arinsburg; R O Francis; J E Hendrickson; J C Zimring; S L Spitalnik
Journal:  Vox Sang       Date:  2010-03-21       Impact factor: 2.144

2.  Whole-blood phenotyping to assess alloimmunization status in transfused sickle cell disease patients.

Authors:  Marie Tamagne; Sadaf Pakdaman; Pablo Bartolucci; Anoosha Habibi; Frédéric Galactéros; France Pirenne; Benoît Vingert
Journal:  Blood Adv       Date:  2021-03-09

3.  Absence of the spleen and the occurrence of primary red cell alloimmunization in humans.

Authors:  Dorothea Evers; Johanna G van der Bom; Janneke Tijmensen; Masja de Haas; Rutger A Middelburg; Karen M K de Vooght; Daan van de Kerkhof; Otto Visser; Nathalie C V Péquériaux; Francisca Hudig; Jaap Jan Zwaginga
Journal:  Haematologica       Date:  2017-04-14       Impact factor: 9.941

Review 4.  Cellular immune responses in red blood cell alloimmunization.

Authors:  James C Zimring; Krystalyn E Hudson
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

5.  A locus on chromosome 5 shows African ancestry-limited association with alloimmunization in sickle cell disease.

Authors:  Lesedi M Williams; Zhihua Qi; Ken Batai; Stanley Hooker; Nancy J Hall; Roberto F Machado; Alice Chen; Sally Campbell-Lee; Yongtao Guan; Rick Kittles; Neil A Hanchard
Journal:  Blood Adv       Date:  2018-12-26

6.  Immunologic characterization suggests reduced alloimmunization in a murine model of thalassemia intermedia.

Authors:  Weili Bao; Hui Zhong; Karina Yazdanbakhsh
Journal:  Transfusion       Date:  2014-05-05       Impact factor: 3.157

7.  Recipient priming to one RBC alloantigen directly enhances subsequent alloimmunization in mice.

Authors:  Seema R Patel; Ashley Bennett; Kathryn Girard-Pierce; Cheryl L Maier; Satheesh Chonat; Connie M Arthur; Patricia E Zerra; Amanda Mener; Sean R Stowell
Journal:  Blood Adv       Date:  2018-01-23

8.  Red blood cell alloimmunization is influenced by the delay between Toll-like receptor agonist injection and transfusion.

Authors:  Rahma Elayeb; Marie Tamagne; Philippe Bierling; France Noizat-Pirenne; Benoît Vingert
Journal:  Haematologica       Date:  2015-10-01       Impact factor: 9.941

Review 9.  Alteration of lymphocyte phenotype and function in sickle cell anemia: Implications for vaccine responses.

Authors:  Emmanuel Balandya; Teri Reynolds; Stephen Obaro; Julie Makani
Journal:  Am J Hematol       Date:  2016-07-14       Impact factor: 10.047

10.  HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease.

Authors:  Marianne E McPherson; Alan R Anderson; Marta-Inés Castillejo; Christopher D Hillyer; Robert A Bray; Howard M Gebel; Cassandra D Josephson
Journal:  Pediatr Blood Cancer       Date:  2010-04       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.